In nanoparticle (NP)-mediated drug delivery, liposomes are the most widely used drug
carrier, and the only NP system currently approved by the FDA for clinical use, owing to their …

Cancer theranostics is the combination of diagnosis and therapeutic approaches for cancer,
which is essential in personalized cancer treatment. The aims of the theranostics application …

One of the imperative medical requirements for cancer treatment is how to establish an
imaging‐guided nanocarrier that combines therapeutic and imaging agents into one system …

Nanocarrier-based drug delivery systems hold impressive promise for biomedical
application because of their excellent water dispersibility, prolonged blood circulation time …

Hepatocellular carcinoma (HCC) is the most common type of liver cancer and one of the
leading causes of cancer-related death worldwide. Advanced HCC displays strong …

Light is a uniquely powerful tool for controlling molecular events in biology. No other
external input (eg, heat, ultrasound, magnetic field) can be so tightly focused or so highly …

Nanomedicines overcome the pharmacokinetic limitations of traditional drug formulations
and have promising prospect in cancer treatment. However, nanomedicine delivery in vivo is …

Engineered liposomal nanoparticles have unique characteristics as cargo carriers in cancer
care and therapeutics. Liposomal theranostics have shown significant progress in preclinical …

Despite the tremendous efforts made in the past decades, severe side/toxic effects and poor
bioavailability still represent the main challenges that hinder the clinical translation of drug …

The past few decades have seen emerging growth in the field of soft materials for synthetic
biology. This review focuses on soft materials involved in biological and artificial …